The goal of this study was to determine the best predictive factor among image-derived parameters extracted from sequential 18 F-FDG Positron Emission Tomography (PET) scans for early tumor response prediction after two cycles of neoadjuvant chemotherapy (NAC) in breast cancer.
pCR (13) .
11
To the best of our knowledge, no study has investigated the predictive value, 12 regarding response to NAC for breast cancer, for all of the previously described 18 
F-

13
FDG PET image derived parameters (SUV max , SUV mean , SUV peak , TLG, MATV) within 14 the same study, at both the baseline and during treatment time points.
15
The current study was therefore conducted with the objective of determining the 
MATERIALS AND METHODS
20
Patient Population
21
The current study consists of a retrospective analysis of a prospective cohort of 55 22 consecutive patients diagnosed with breast cancer included in a previous clinical trial 23 (14) , performed in agreement with guidelines of the institutional ethical committee 24 with patients' informed consent. PET/CT image datasets of 3 patients could not be completion of chemotherapy, all patients underwent surgery (mastectomy or 9 lumpectomy). 
15
Three specific tumor subgroups as described previously were considered, namely 16 triple-negative, ER-positive/HER2-negative (luminal) and HER2-positive. (15) , that was used in the frequently cited study by Rousseau et al (6) :
22
TA: total or nearly-total therapeutic effect, TB: >50% therapeutic effect but less than 23 total or nearly-total effect, TC: <50% therapeutic effect but visible effect, TD: no 24 therapeutic effect, NA: evidence of therapeutic effect and no residual disease, NB: no node metastases or therapeutic effect, NC: evidence of a therapeutic effect but 1 metastasis still present, ND: metastasis still present and viable, no therapeutic effect. 
5
The pCR rate, defined as absence of invasive cancer cells in the primary tumor and 6 in lymph nodes (16) was also evaluated and the predictive power of PET parameters 7 to predict pCR was measured. 
Investigated Parameters and Analysis
10
All PET image-derived parameters were extracted from the PET 1 and PET 2 images.
11
For each patient, the primary tumor was identified on the PET image by a nuclear 12 medicine physician with more than 10 years experience and subsequently semi- 
Statistical Analysis
16
Statistical analyses were performed using MedCalc TM (MedCalc Software, Belgium).
17
All parameters' distributions were expressed as median (or mean depending on 18 normality) ± standard deviations (SD) and range (minimum, maximum). Normality (table 2) . Similarly, the 21 distribution of responders and non-responders groups were not normally distributed
22
(figure 2), except for the variation (Δ) values (figure 3).
23
According to Mann-Whitney-U tests, no significant correlation (p>0. respectively (figure 5A).
21
Impact of Partial Volume Effects Correction
23
The correction of partial volume effects had no significant impact on the resulting 24 variation (Δ) of neither SUV nor volume-based parameters, despite the significant impact on their PET 1 and PET 2 absolute values. There were therefore no statistically 1 significant differences between the AUCs of ROC curves generated using Δ(%) 2 calculated using the original and PVC PET image derived parameters ( figure 4B , 5B). The absolute values of some parameters (SUV max and TLG) after the second cycle 4 (PET 2 ) were significantly correlated with response but had limited predictive value.
5
The most powerful predictive factors were the evolution between the baseline and 6 the second scan (Δ). PVC eliminated significant differences in % FDG uptake measurement changes for were also larger; -48% for SUV max , which is in accordance to previous findings (8), -
14
42% and -56% for MATV and TLG respectively. power demonstrated by Mann-Whitney-U tests (table 2) .
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